Home
therapeutics focus
Overview
Diabetic Retinopathy
Disease Progression
Follow On Indications
PRoduct Overview
Resolv ER™
MECHANISM of action
Intellectual property
CLInical Trials
PHASE 1b
PHASE 2
ABOUT US
LEADERSHIP
Clinical Advisors
scientific advisiors
NEWS
CONTACT us
IMAGE GALLERY
Kato is a clinical stage Biopharmaceutical company
dedicated to the development of novel therapies
for pathologies of the eye with an emphasis on unmet medical needs.
Learn More